Clearline Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-51,933
Closed -$763K 114
2024
Q3
$763K Buy
51,933
+14,800
+40% +$206K 0.03% 127
2024
Q2
$536K Sell
37,133
-353,066
-90% -$5.64M 0.01% 130
2024
Q1
$6.35M Sell
390,199
-261,773
-40% -$4.09M 0.31% 49
2023
Q4
$9.71M Sell
651,972
-786,793
-55% -$8.91M 0.6% 30
2023
Q3
$16.2M Hold
1,438,765
1.39% 21
2023
Q2
$14.5M Buy
1,438,765
+608,529
+73% +$5.65M 0.84% 17
2023
Q1
$7.8M Buy
830,236
+246,112
+42% +$2.9M 1.18% 30
2022
Q4
$7.14M Sell
584,124
-32,559
-5% -$406K 1.28% 23
2022
Q3
$7.65M Buy
616,683
+125,384
+26% +$2.19M 0.92% 30
2022
Q2
$9.64M Hold
491,299
1.25% 27
2022
Q1
$12.8M Buy
491,299
+84,382
+21% +$2.25M 1.47% 21
2021
Q4
$11.5M Sell
406,917
-36,600
-8% -$1.14M 1.27% 26
2021
Q3
$14.1M Buy
443,517
+279,255
+170% +$9.37M 1.33% 17
2021
Q2
$5.7M Sell
164,262
-12,093
-7% -$399K 0.85% 39
2021
Q1
$5.19M Buy
+176,355
New +$5.42M 0.67% 38

Other funds holding ELAN

Clearline Capital's ELAN Position: Q4 2024 in Review

Clearline Capital sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 51,933 shares — an estimated $763K sold.

Clearline Capital first reported a position in ELAN in Q1 2021 and held it in 15 quarters. The position peaked at $16.2M in Q3 2023. 394 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • Clearline Capital reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • Clearline Capital sold 51,933 Elanco Animal Health shares in Q4 2024, an estimated $763K.
  • Clearline Capital first reported a position in Elanco Animal Health in Q1 2021 and held it in 15 quarters.
  • Clearline Capital's Elanco Animal Health position peaked at $16.2M in Q3 2023.
  • 394 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.